INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Public company

DNAGinkgo Bioworks Holdings, Inc.

CIK 0001830214

EDGAR filingsOpen in network
Disclosed transactions59
Buys / sells0 / 15
Max Insider Score50
Connections5with evidence

DNA · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
15
CB
Canton Barry10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
26.8K sh
Oct 16, 2026Oct 21, 2026
traded Oct 16, 2026
+5dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
  • ← Insider ofevidence
    Kelly Jason RDirector, See remarks · Oct 21, 2026
  • ← Insider ofevidence
    Coen Steven P.See remarks · Apr 14, 2026
  • ← Insider ofevidence
    Shetty Reshma P.Director, See remarks, 10% Owner · Apr 10, 2026
11
CP
Coen Steven P.See remarks
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M
—
1,174 sh
Oct 16, 2026
Oct 21, 2026
traded Oct 16, 2026
+5d
SEC FORM 4

Evidence

32
CP
Coen Steven P.See remarks
DNAGinkgo Bioworks Holdings, Inc.
Open-market sale
SELL$7,770
766 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC FORM 4

Evidence

19
CP
Coen Steven P.See remarks
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
1,174 sh
Oct 16, 2026Oct 21, 2026
traded Oct 16, 2026
+5dSEC FORM 4

Evidence

15
CP
Coen Steven P.See remarks
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
312 sh
Oct 16, 2026Oct 21, 2026
traded Oct 16, 2026
+5dSEC FORM 4

Evidence

39
CB
Canton Barry10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Open-market sale
SELL$191K
18.8K sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC FORM 4

Evidence

35
SP
Shetty Reshma P.Director, See remarks, 10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Open-market sale
SELL$227K
22.4K sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC FORM 4

Evidence

15
SP
Shetty Reshma P.Director, See remarks, 10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
26.8K sh
Oct 16, 2026Oct 21, 2026
traded Oct 16, 2026
+5dSEC FORM 4

Evidence

11
SP
Shetty Reshma P.Director, See remarks, 10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
29.3K sh
Oct 16, 2026Oct 21, 2026
traded Oct 16, 2026
+5dSEC FORM 4

Evidence

15
SP
Shetty Reshma P.Director, See remarks, 10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
10.6K sh
Oct 16, 2026Oct 21, 2026
traded Oct 16, 2026
+5dSEC FORM 4

Evidence

11
CP
Coen Steven P.See remarks
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
312 sh
Oct 16, 2026Oct 21, 2026
traded Oct 16, 2026
+5dSEC FORM 4

Evidence

11
CB
Canton Barry10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
9,762 sh
Oct 16, 2026Oct 21, 2026
traded Oct 16, 2026
+5dSEC FORM 4

Evidence

15
CB
Canton Barry10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
29.3K sh
Oct 16, 2026Oct 21, 2026
traded Oct 16, 2026
+5dSEC FORM 4

Evidence

11
CB
Canton Barry10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
10.6K sh
Oct 16, 2026Oct 21, 2026
traded Oct 16, 2026
+5dSEC FORM 4

Evidence

35
CB
Canton Barry10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Open-market sale
SELL$227K
22.4K sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC FORM 4

Evidence

11
CB
Canton Barry10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
26.8K sh
Oct 16, 2026Oct 21, 2026
traded Oct 16, 2026
+5dSEC FORM 4

Evidence

15
CB
Canton Barry10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
9,762 sh
Oct 16, 2026Oct 21, 2026
traded Oct 16, 2026
+5dSEC FORM 4

Evidence

11
CB
Canton Barry10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
29.3K sh
Oct 16, 2026Oct 21, 2026
traded Oct 16, 2026
+5dSEC FORM 4

Evidence

15
CB
Canton Barry10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
10.6K sh
Oct 16, 2026Oct 21, 2026
traded Oct 16, 2026
+5dSEC FORM 4

Evidence

15
SP
Shetty Reshma P.Director, See remarks, 10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
29.3K sh
Oct 16, 2026Oct 21, 2026
traded Oct 16, 2026
+5dSEC FORM 4

Evidence

11
SP
Shetty Reshma P.Director, See remarks, 10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
10.6K sh
Oct 16, 2026Oct 21, 2026
traded Oct 16, 2026
+5dSEC FORM 4

Evidence

11
SP
Shetty Reshma P.Director, See remarks, 10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
26.8K sh
Oct 16, 2026Oct 21, 2026
traded Oct 16, 2026
+5dSEC FORM 4

Evidence

15
SP
Shetty Reshma P.Director, See remarks, 10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
9,762 sh
Oct 16, 2026Oct 21, 2026
traded Oct 16, 2026
+5dSEC FORM 4

Evidence

27
KR
Kelly Jason RDirector, See remarks
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
55.7K sh
Oct 16, 2026Oct 21, 2026
traded Oct 16, 2026
+5dSEC FORM 4

Evidence

19
KR
Kelly Jason RDirector, See remarks
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
25.8K sh
Oct 16, 2026Oct 21, 2026
traded Oct 16, 2026
+5dSEC FORM 4

Evidence

50
KR
Kelly Jason RDirector, See remarks
DNAGinkgo Bioworks Holdings, Inc.
Open-market sale
SELL$463K
45.7K sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC FORM 4

Evidence

15
KR
Kelly Jason RDirector, See remarks
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
55.7K sh
Oct 16, 2026Oct 21, 2026
traded Oct 16, 2026
+5dSEC FORM 4

Evidence

11
SP
Shetty Reshma P.Director, See remarks, 10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
9,762 sh
Oct 16, 2026Oct 21, 2026
traded Oct 16, 2026
+5dSEC FORM 4

Evidence

39
SP
Shetty Reshma P.Director, See remarks, 10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Open-market sale
SELL$191K
18.8K sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC FORM 4

Evidence

19
KR
Kelly Jason RDirector, See remarks
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
25.8K sh
Oct 16, 2026Oct 21, 2026
traded Oct 16, 2026
+5dSEC FORM 4

Evidence

32
CP
Coen Steven P.See remarks
DNAGinkgo Bioworks Holdings, Inc.
Open-market sale
SELL$36K
2,403 sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC FORM 4

Evidence

27
CP
Coen Steven P.See remarks
DNAGinkgo Bioworks Holdings, Inc.
Open-market sale
SELL$2,576
324 sh
Apr 17, 2026Apr 20, 2026
traded Apr 17, 2026
+3dSEC FORM 4

Evidence

9
CP
Coen Steven P.See remarks
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
587 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC FORM 4

Evidence

5
CP
Coen Steven P.See remarks
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
156 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC FORM 4

Evidence

5
CP
Coen Steven P.See remarks
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
587 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC FORM 4

Evidence

5
CP
Coen Steven P.See remarks
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
156 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC FORM 4

Evidence

21
CP
Coen Steven P.See remarks
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
45.6K sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC FORM 4

Evidence

42
CP
Coen Steven P.See remarks
DNAGinkgo Bioworks Holdings, Inc.
Open-market sale
SELL$213K
33.2K sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC FORM 4

Evidence

9
CP
Coen Steven P.See remarks
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
45.6K sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC FORM 4

Evidence

21
CP
Coen Steven P.See remarks
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
28.4K sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC FORM 4

Evidence

9
CP
Coen Steven P.See remarks
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
28.4K sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC FORM 4

Evidence

41
CB
Canton Barry10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Open-market sale
SELL$802K
124.7K sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC FORM 4

Evidence

17
CB
Canton Barry10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
251.8K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC FORM 4

Evidence

5
CB
Canton Barry10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
251.8K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC FORM 4

Evidence

17
SP
Shetty Reshma P.Director, See remarks, 10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
251.8K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC FORM 4

Evidence

41
SP
Shetty Reshma P.Director, See remarks, 10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Open-market sale
SELL$802K
124.7K sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC FORM 4

Evidence

5
SP
Shetty Reshma P.Director, See remarks, 10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
251.8K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC FORM 4

Evidence

15
CB
Canton Barry10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
27.7K sh
Apr 7, 2026Apr 10, 2026
traded Apr 7, 2026
+3dSEC FORM 4

Evidence

19
SP
Shetty Reshma P.Director, See remarks, 10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
27.7K sh
Apr 7, 2026Apr 10, 2026
traded Apr 7, 2026
+3dSEC FORM 4

Evidence

13
SP
Shetty Reshma P.Director, See remarks, 10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
27.7K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC FORM 4

Evidence

34
SP
Shetty Reshma P.Director, See remarks, 10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Open-market sale
SELL$91K
13.2K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC FORM 4

Evidence

30
SP
Shetty Reshma P.Director, See remarks, 10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Open-market sale
SELL$84K
13.1K sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC FORM 4

Evidence

15
SP
Shetty Reshma P.Director, See remarks, 10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
27.7K sh
Apr 7, 2026Apr 10, 2026
traded Apr 7, 2026
+3dSEC FORM 4

Evidence

9
SP
Shetty Reshma P.Director, See remarks, 10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
27.7K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC FORM 4

Evidence

9
CB
Canton Barry10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
27.7K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC FORM 4

Evidence

19
CB
Canton Barry10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
27.7K sh
Apr 7, 2026Apr 10, 2026
traded Apr 7, 2026
+3dSEC FORM 4

Evidence

13
CB
Canton Barry10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
27.7K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC FORM 4

Evidence

34
CB
Canton Barry10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Open-market sale
SELL$91K
13.2K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC FORM 4

Evidence

30
CB
Canton Barry10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Open-market sale
SELL$84K
13.1K sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Canton Barry10% Owner · Apr 10, 2026